Chartwell Investment Partners’s Viridian Therapeutics VRDN Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q4 | – | Sell |
-39,600
| Closed | -$608K | – | 446 |
|
2023
Q3 | $608K | Hold |
39,600
| – | – | 0.02% | 384 |
|
2023
Q2 | $942K | Buy |
39,600
+6,001
| +18% | +$143K | 0.03% | 357 |
|
2023
Q1 | $855K | Sell |
33,599
-27,453
| -45% | -$699K | 0.03% | 356 |
|
2022
Q4 | $1.78M | Buy |
61,052
+3,488
| +6% | +$102K | 0.07% | 275 |
|
2022
Q3 | $1.18M | Buy |
+57,564
| New | +$1.18M | 0.05% | 329 |
|